1. Dr. Wu Zunyou, Chief Epidemiologist, China CDC.
2. Professor Yong-Zhen Zhang, Shanghai Public Health Clinical Center & School of Public Health, Fudan University, Shanghai, China : The Shanghai Public Health Clinical Center & School of Public Health, in collaboration with the Central Hospital of Wuhan, Huazhong University of Science and Technology, the Wuhan Center for Disease Control and Prevention, the National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control, and the University of Sydney, Sydney, Australia is releasing a coronavirus genome from a case of a respiratory disease from the Wuhan outbreak. The sequence has also been deposited on GenBank (accession MN908947) and will be released as soon as possible.
   
3. ChinaNews.com; “The discovery of nucleic acid, genomic and antibody evidence of the pathogen from patients can be accomplished in a short period of time. Scientific studies such as the isolation and pathogenicity identification of the pathogen can take several weeks;” https://www.youtube.com/watch?v=jggndUgvhrk
   
4. Laboratory testing of human suspected cases of novel coronavirus (nCoV) infection; • “The etiologic agent responsible for the cluster of pneumonia cases in Wuhan has not yet been fully verified, but a novel Betacoronavirus has reportedly been cultured from at least one pneumonia patient and characterized by electron microscopy and genome sequencing and has been detected by PCR in 15 other patients (12). It is expected that full gene sequence and other information on the putative causative agent will soon be available that can inform the development of specific diagnostic tests. Until that time, the goals of diagnostic testing are to detect suspect cases early, to support disease control activities, and to work with reference laboratories that can perform pathogen discovery and additional testing to clarify the pathogenic role of the putative emergent cause of respiratory disease.” • “Once genome sequences of the novel coronavirus have been released and specific NAAT assays developed, confirmation of cases of the novel virus infection will be based on specific detection of unique sequences of viral nucleic acid by reverse-transcriptase polymerase chain reaction (RT-PCR) with probe detection or sequencing.”
   

plus-circle Add Review

comment

Reviews